Deutetrabenazine is not currently approved for use in India. It is a medication used to treat chorea associated with Huntington's disease and tardive dyskinesia. [1]
When Might Deutetrabenazine Be Available in India?
The availability of deutetrabenazine in India depends on regulatory approvals from the Indian government. Pharmaceutical companies must submit applications and undergo review processes before a drug can be marketed. Information regarding specific timelines for such submissions or approvals for deutetrabenazine in India is not publicly available.
What is Deutetrabenazine Used For?
Deutetrabenazine is a prescription medication approved in the United States for the treatment of chorea, a movement disorder characterized by involuntary, irregular, and jerky movements, which is a symptom of Huntington's disease. It is also approved for the treatment of tardive dyskinesia, another movement disorder caused by long-term use of certain antipsychotic medications. [1]
How Does Deutetrabenazine Work?
Deutetrabenazine works by affecting the levels of certain chemicals, known as neurotransmitters, in the brain, specifically dopamine. By reducing the amount of dopamine available, it helps to control the involuntary movements associated with conditions like Huntington's disease and tardive dyskinesia. [1]
What Are the Side Effects of Deutetrabenazine?
Common side effects associated with deutetrabenazine can include drowsiness, fatigue, insomnia, nausea, vomiting, and diarrhea. More serious side effects may occur, and patients should discuss potential risks with their healthcare provider. [1]
Are There Alternatives to Deutetrabenazine for Movement Disorders in India?
For individuals in India experiencing movement disorders like chorea or tardive dyskinesia, alternative treatment options may exist. These could include other medications that manage neurotransmitter levels, therapies aimed at improving motor control, or interventions tailored to the specific underlying condition. Consulting with a neurologist or movement disorder specialist in India would be the best approach to understand available treatment pathways.